Expression levels of immunophenotypic markers in the two groups formed at the extremes of heatmap (group 1 and group 3) with different clinical characteristics. No statistically significant differences were observed in the expression of CD20, CD58, CD66, CD117, CD34, CD33, SmIgM, CD13, Lambda, CD9, TdT, CD22, CD24, SSC. (TIFF 1519 kb
Figure S1. Fluorescence-activated cell sorting of CD133 in gastric cancer cell lines. CD133- cells w...
Additional file 3: Figure S3. Transcriptome features of COVPRIG-based group. (A) Volcano plot of DEG...
Gene expression pattern in subpopulations of B-ALL cells. (A, B) The immunophenotypes of patients #1...
Table S2. Complete set of genes differentially expressed between good (n = 22) versus poor (n = 5) i...
Table S1. Clinical and molecular baseline characteristics of patients. Clinical and molecular data o...
Table S3. Complete list of signaling pathways dysregulated in patients who failed to complete remiss...
Figure S2. Predictive power of ID4 mRNA expression for overall survival (OS) was evaluated by Kaplan...
Figure S3. Bioinformatics analysis of human iPSC differentiated ECs and HSPCs. a Heatmap analysis of...
Table S1. Comparison of clinicopathological features of TNBC patients bearing high or low PD-L1 tumo...
Figure S3. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Survival outcomes for stage IIIA and combined stage IIIB & IIIC patients with molecular classificati...
Additional file 1: Figure S1. Identification of ICDRS prognostic value in lung adenocarcinoma (LUAD)...
Complete file derived from pathway analysis in patients who failed to remission therapy. Signaling a...
Table S1. Differentially expressed genes in CD133 + −vs.-CD133- gastric cancer cell lines. A total o...
Table S1. Associations between median cancer CXCL13 expression and patient and tumor characteristics...
Figure S1. Fluorescence-activated cell sorting of CD133 in gastric cancer cell lines. CD133- cells w...
Additional file 3: Figure S3. Transcriptome features of COVPRIG-based group. (A) Volcano plot of DEG...
Gene expression pattern in subpopulations of B-ALL cells. (A, B) The immunophenotypes of patients #1...
Table S2. Complete set of genes differentially expressed between good (n = 22) versus poor (n = 5) i...
Table S1. Clinical and molecular baseline characteristics of patients. Clinical and molecular data o...
Table S3. Complete list of signaling pathways dysregulated in patients who failed to complete remiss...
Figure S2. Predictive power of ID4 mRNA expression for overall survival (OS) was evaluated by Kaplan...
Figure S3. Bioinformatics analysis of human iPSC differentiated ECs and HSPCs. a Heatmap analysis of...
Table S1. Comparison of clinicopathological features of TNBC patients bearing high or low PD-L1 tumo...
Figure S3. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Survival outcomes for stage IIIA and combined stage IIIB & IIIC patients with molecular classificati...
Additional file 1: Figure S1. Identification of ICDRS prognostic value in lung adenocarcinoma (LUAD)...
Complete file derived from pathway analysis in patients who failed to remission therapy. Signaling a...
Table S1. Differentially expressed genes in CD133 + −vs.-CD133- gastric cancer cell lines. A total o...
Table S1. Associations between median cancer CXCL13 expression and patient and tumor characteristics...
Figure S1. Fluorescence-activated cell sorting of CD133 in gastric cancer cell lines. CD133- cells w...
Additional file 3: Figure S3. Transcriptome features of COVPRIG-based group. (A) Volcano plot of DEG...
Gene expression pattern in subpopulations of B-ALL cells. (A, B) The immunophenotypes of patients #1...